Influenza A hemagglutinin protein stem region (HA stem)

The **Influenza A hemagglutinin protein stem region** is a highly conserved domain of the hemagglutinin (HA) trimeric glycoprotein found on the surface of Influenza A viruses. HA mediates two essential steps in the viral life cycle: binding of the virus to sialic acid-containing receptors on host cells (via the globular "head" domain) and fusion of the viral envelope with the host endosomal membrane (via the "stem" or "stalk" domain). The stem region (largely formed by the HA2 subunit) contains the fusion peptide responsible for mediating this membrane fusion after endosomal acidification. This region is much less variable than the head domain, making it an attractive target for broadly neutralizing antibodies and the focal point for universal influenza vaccine development and therapeutic antibody strategies. Drugs or antibodies targeting the HA stem region function by blocking the conformational rearrangements required for membrane fusion, thereby inhibiting viral entry into host cells. The main therapeutic challenge is the potential for viral escape by glycan shielding or mutation of epitope residues. No small-molecule drugs currently target this region exclusively in clinical use, but several monoclonal antibodies are in development or clinical trials targeting this conserved domain.

Other names

Influenza A HA stemHemagglutinin stemInfluenza hemagglutinin stalk regionInfluenza virus HA stem region

Neutralizing antibodies prevent conformational changes in the stem that are required for membrane fusion, thereby blocking viral entry. Inhibitors can prevent the fusion of viral and host membranes by stabilizing the prefusion conformation of HA.